Addex Therapeutics LTD. (ADXN) SEC Filings — 2024
17 SEC filings for Addex Therapeutics LTD. (ADXN) in 2024.
Filings
- Addex Therapeutics Files 6-K, Incorporates Exhibits — 6-K · Nov 22, 2024
- Addex Therapeutics Files 6-K, Incorporates Press Release — 6-K · Nov 12, 2024
- Addex Therapeutics Files 6-K, Incorporates Exhibits — 6-K · Sep 30, 2024
- Addex Therapeutics Files 6-K with Press Release — 6-K · Sep 19, 2024
- Addex Therapeutics Files 6-K with Press Release — 6-K · Aug 27, 2024
- Growth Equity Fund Adjusts Addex Therapeutics Stake — SC 13D/A · Aug 14, 2024
- Growth Equity Fund Updates Addex Therapeutics Stake — SC 13D/A · Aug 5, 2024
- Addex Therapeutics Files 6-K with Press Release — 6-K · Jul 22, 2024
- Addex Therapeutics Files 6-K with Press Release — 6-K · Jul 15, 2024
- Addex Therapeutics Files Form 6-K with Press Release — 6-K · Jul 1, 2024
- Addex Therapeutics Files 6-K, Incorporates Exhibits — 6-K · Jun 6, 2024
- Addex Therapeutics Files 6-K with Press Release — 6-K · Jun 5, 2024
- Addex Therapeutics Files 6-K, Incorporates Press Release — 6-K · Apr 29, 2024
- Addex Therapeutics Files 6-K with Press Release — 6-K · Apr 18, 2024
- Addex Therapeutics Ltd. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — 20-F · Apr 18, 2024
- Addex Therapeutics Files 6-K, Incorporates Press Release — 6-K · Apr 3, 2024
- Addex Therapeutics Terminates Cantor Fitzgerald Sales Agreement — 6-K · Jan 30, 2024